Dr Jalil A Khan, M.D,P.A is the Founder, President and CEO of our facility, which specializes in Preventive Cardiology, General Cardiology and all subareas of Internal Medicine practice. He is Board certified in Internal Medicine, 1995; Fellowship Trained in Preventive Cardiology, 1996 and from UT SouthWestern Medical Center Dallas,TX with Active Texas Medical License since 1995. He is Chair of American Annual Convention Dallas, Vice Chair of Medicine, Medical Center Of Lewisville. Member of Texas Medical Association, Denton Medical Society with 25 years of Clinical experience in patient care and Medical Research.
On the beauty side of Dr. Jalil A. Khan’s practice, his expertise in the field of Medicine are not just restricted to patient care but his passion for research has made him establish a firm footage in the industry of Clinical Trials and Clinical Research projects as Principal Investigator for our lead sponsors such as: Novartis, Novo Nordisk, Gilead, Nexbio, Takeda, Eisai.
Since 2003, our facility is a approved site for clinical trials conducted with strict study protocol adherence and IRB Approval as Dr. Jalil A Khan, as Principal Investigator.Our status for all our clinical trials can be verified from www.clinicaltrials.gov.
Dr. Jalil A Khan is a prominent researcher,his Active Areas of Research are Type 2 Diabetes Mellitus and cardiovascular complications, Acute Coronary Syndrome,Blood Pressure reduction in resistant hypertension, Influenza, Rheumatoid Arthritis,and Metabolic Syndrome.